Manning Meredith
Insider CIK 1752631 · SLNO Chief Commercial Officer · TORC Chief Commercial Officer · UNCY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-10-28 | 2026-10-29 | 27,000 | — | $0 | 27,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-10-28 | 2026-10-29 | 3,350 | — | $0 | 3,350 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 32,800 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 29,200 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer deriv | 2026-05-18 | 2026-05-18 | 91,000 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer | 2026-05-18 | 2026-05-18 | 64,507 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2026-03-27 | 2026-03-31 | 4,864 | $30.04 | $146.1K | 67,165 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2026-03-27 | 2026-03-31 | 2,100 | $31.04 | $65.2K | 65,065 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2026-03-27 | 2026-03-31 | 558 | $31.72 | $17.7K | 64,507 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2026-01-21 | 2026-01-23 | 32,800 | — | $0 | 32,800 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2026-01-21 | 2026-01-23 | 28,600 | — | $0 | 72,029 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | F Tax w/h | 2025-12-15 | 2025-12-17 | 1,922 | $49.95 | $96.0K | 43,429 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | M Exercise deriv | 2025-03-27 | 2025-03-31 | 37,000 | — | $0 | 91,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 37,000 | $67.04 | $2.48M | 45,351 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 668 | $65.97 | $44.1K | 52,932 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 1,087 | $66.79 | $72.6K | 51,845 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 1,976 | $67.70 | $133.8K | 49,869 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 2,599 | $68.79 | $178.8K | 47,270 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 1,505 | $69.84 | $105.1K | 45,765 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 155 | $70.73 | $11.0K | 45,610 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 225 | $71.74 | $16.1K | 45,385 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-31 | 34 | $72.64 | $2.5K | 45,351 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | M Exercise | 2025-03-27 | 2025-03-31 | 37,000 | $46.31 | $1.71M | 82,351 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 29,200 | — | $0 | 29,200 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2025-01-21 | 2025-01-23 | 13,600 | — | $0 | 53,600 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2024-07-17 | 2024-07-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2019-02-27 | 2019-02-28 | 26,000 | — | $0 | 26,000 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2018-09-17 | 2018-09-18 | 175,000 | — | $0 | 175,000 | SEC↗ |